Clue app secures 'substantial' investment from Verdane's €2 billion growth fund
Single largest investment in Clue to date
The Berlin-based women-led period and cycle tracking app Clue has secured a ‘significant and strategic’ investment from specialist growth buyout investment firm Verdane.
The investment into Clue is described as a ‘substantial contribution from Verdane’s €2 billion growth fund’. Exact figures have not been disclosed but it is confirmed as the single largest investment in Clue to date; the previous largest was $7.6m in 2023.
The funding also means Verdane is now the largest investor in the women’s health and wellness app and follows a year in 2025 that strengthened Clue’s growth foundations and created a clear path to long-term and sustainable profitability.
Rhiannon White, CEO at Clue, said:
“Partnering with Verdane enables us to accelerate the creation of this powerful ecosystem and tackle these issues for women.
“Verdane’s deep expertise in growing sustainable businesses, combined with their extensive operating experience in the health and wellness space means they bring unparalleled support to the opportunity in front of us.”
With Verdane’s partnership, Clue plans to accelerate its next phase of growth including deepening product innovation, user experience and feature development; expanding global reach; investing in healthcare partnerships to expand access; invest in more research to continue to close the women’s health gap; strengthening its privacy-first approach; and investing in technology that aids in delivering more personalised care.
“We are highly impressed by the Clue management team and the strong momentum the business is demonstrating,” commented Christina Stoll, Principal at Verdane.
“Clue has earned exceptional user trust by combining the highest data protection standards with rigorous, science-based insights in a category where credibility truly matters. Consumer demand and awareness for trusted women’s health solutions continues to accelerate, and Clue is uniquely positioned to lead this space.”
A potential for impact
Clue and Verdane have said that they share a belief women’s health remains one of the most underserved, and most impactful, categories in global health and wellness. Both organisations recognise the opportunity to build category-defining companies that combine scientific rigor, ethical data practices, and long-term thinking to deliver meaningful outcomes for users and society.
‘’Women are the world’s largest health and wellness consumers, controlling the majority of household spending in every market, yet they remain strikingly underserved relative to their economic power,” said Rhiannon White.
“This gap creates three systemic pain points: a profound lack of accessible female health knowledge that forces women to self-diagnose, a confusing marketplace filled with unproven products and little evidence-based guidance, and persistent barriers to accessing care. For businesses, this represents not just a social issue but a significant market failure and a compelling opportunity to build trusted, data driven solutions that meet the needs of the most influential spenders in global health and wellness.”
Founded in 2012 by Ida Tin, Hans Raffauf, Mike LaVigne and Moritz von Buttlar and then launched in 2013, Clue has long differentiated itself through its commitment to medical research, and scientific-based insights, leading data privacy standards, and an inclusive approach to women’s health that goes beyond fertility tracking alone.
Verdane will bring deep experience partnering with mission-driven, digital-first companies, helping them scale responsibly while staying true to their values and ethical positioning. Its investment philosophy, which is centered on sustainable growth, operational excellence and building enduring market leaders, aligns closely with Clue’s ambition to set the global standard for digital women’s health and wellness.
“With Verdane’s sector expertise in scaling digital health and wellbeing platforms, we are confident that we can be a strong long-term partner to the team, supporting continued growth, product innovation and an outstanding user experience, while deepening valuable partnerships across the health and wellbeing ecosystem,” continued Christina Stoll.
“Clue’s women-led, mission-driven approach and focus on meaningful impact strongly align with what Verdane stands for.”